Skip to main content

Artificial Intelligence

By Bill Siwicki | 12:35 pm | February 06, 2020
Its message to attendees will revolve around clinical documentation and how it is using AI, machine learning, NLP and more to ease physician workloads and enhance patient experiences.
By Healthcare IT News | 10:25 am | February 06, 2020
We're looking for presentations with practical tips showing how hospitals and health systems have implemented machine learning and AI to improve care, control costs and drive operational efficiencies.
By HIMSS TV | 07:00 am | February 06, 2020
GE Healthcare Enterprise Imaging Solutions' Omar Sunna says partnering with cloud technology vendors, academics and international institutes is helping the company's AI platform tackle siloed healthcare data.
By Bill Siwicki | 01:07 pm | February 05, 2020
They will be in the Nuance AI Marketplace for Diagnostic Imaging, which is designed to provide a one-stop shop for radiologists to review and purchase AI models to improve their workflow.
Emerging Technology
By Bill Siwicki | 01:12 pm | January 31, 2020
The medical doctor who heads the consulting giant’s global health practice foresees AI having a huge impact in healthcare this year, and is keeping his eyes on blockchain, extended reality and quantum computing.
By Leontina Postelnicu | 01:08 pm | January 31, 2020
One hundred and forty million pounds will be made available over the next three years to scale up AI technologies across the NHS.
By Bill Siwicki | 01:02 pm | January 31, 2020
The IT giant’s global chief medical officer and vice president of healthcare speaks candidly on healthcare and what HIMSS20 attendees need to know.
By Mike Restuccia | 12:48 pm | January 31, 2020
It's hard for me to believe, but I’ve been at Penn Medicine for 13 years.
By Dean Koh | 04:08 am | January 31, 2020
Japanese giant Sumitomo Dainippon Pharma and Oxford-headquartered AI-driven drug discovery company Exscientia yesterday announced that they have created a new compound which is in the process of entering human clinical trials in Japan.
By Mike Miliard | 03:26 pm | January 30, 2020
The five-year project will focus on enabling faster medical research innovations, protecting against global health crises and improving access to care, the company says.